ALPS Advisors’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-38,149
| Closed | -$302K | – | 1142 |
|
|
2024
Q2 | $302K | Sell |
38,149
-204
| -0.5% | -$1.61K | ﹤0.01% | 842 |
|
|
2024
Q1 | $357K | Buy |
38,353
+2,917
| +8% | +$27.2K | ﹤0.01% | 790 |
|
|
2023
Q4 | $299K | Sell |
35,436
-2,464
| -7% | -$20.8K | ﹤0.01% | 854 |
|
|
2023
Q3 | $294K | Buy |
+37,900
| New | +$294K | ﹤0.01% | 888 |
|
|
2021
Q2 | – | Sell |
-67,782
| Closed | -$319K | – | 920 |
|
|
2021
Q1 | $319K | Buy |
67,782
+761
| +1% | +$3.58K | ﹤0.01% | 783 |
|
|
2020
Q4 | $479K | Buy |
67,021
+19,291
| +40% | +$138K | 0.01% | 504 |
|
|
2020
Q3 | $509K | Sell |
47,730
-2,966
| -6% | -$31.6K | 0.01% | 436 |
|
|
2020
Q2 | $640K | Sell |
50,696
-16,701
| -25% | -$211K | 0.01% | 414 |
|
|
2020
Q1 | $617K | Sell |
67,397
-7,863
| -10% | -$72K | 0.01% | 408 |
|
|
2019
Q4 | $1.05M | Buy |
75,260
+1,576
| +2% | +$22K | 0.01% | 339 |
|
|
2019
Q3 | $1.27M | Sell |
73,684
-3,408
| -4% | -$58.6K | 0.01% | 267 |
|
|
2019
Q2 | $2.1M | Sell |
77,092
-1,545
| -2% | -$42K | 0.02% | 219 |
|
|
2019
Q1 | $1.51M | Buy |
78,637
+3,394
| +5% | +$65K | 0.01% | 261 |
|
|
2018
Q4 | $707K | Buy |
75,243
+17,844
| +31% | +$168K | 0.01% | 390 |
|
|
2018
Q3 | $1.09M | Buy |
57,399
+10,499
| +22% | +$199K | 0.01% | 369 |
|
|
2018
Q2 | $916K | Buy |
+46,900
| New | +$916K | 0.01% | 353 |
|